Patents by Inventor Michel Kazatchkine

Michel Kazatchkine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Catalytic anti-factor VIII allo-antibodies
    Publication number: 20090208512
    Abstract: The present invention relates to a method of determining the presence of catalytic anti-Factor VIII allo-antibodies capable of degrading Factor VIII in a mammal, and of characterising the cleavage sites in said Factor VIII molecule by said catalytic anti-Factor VIII allo-antibodies. It also relates to an anti-Factor VIII allo-antibody-catalysed Factor VIII degradation inhibitor; and to a pharmaceutical composition comprising said catalytic anti-Factor VIII allo-antibodies which are capable of degrading Factor VIII and which originate from said method of determination; and further to a pharmaceutical composition comprising said anti-Factor VIII allo-antibody-catalysed Factor VIII degradation inhibitor.
    Type: Application
    Filed: January 16, 2009
    Publication date: August 20, 2009
    Inventors: Srinivas Kaveri, Sebastien Lacroix-Desmazes, Michel Kazatchkine
  • Catalytic anti-factor VIII allo-antibodies
    Patent number: 7507540
    Abstract: A method is disclosed of determining the presence of catalytic anti-Factor VIII allo-antibodies capable of degrading Factor VIII in a mammal, and of characterising the cleavage sites in said Factor VIII molecule by said catalytic anti-Factor VIII allo-antibodies. It also relates to an anti-Factor VIII allo-antibody-catalysed Factor VIII degradation inhibitor; and to a pharmaceutical composition comprising said catalytic anti-Factor VIII allo-antibodies which are capable of degrading Factor VIII and which originate from said method of determination; and further to a pharmaceutical composition comprising said anti-Factor VIII allo-antibody-catalysed Factor VIII degradation inhibitor.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: March 24, 2009
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Bayer Pharma
    Inventors: Srinivas Kaveri, Sébastien Lacroix-Desmazes, Michel Kazatchkine